Up-regulation of HLA-G expression in cervical premalignant and malignant lesions

Tissue Antigens

Volumn 77, Issue 3, 2011, Pages 218-224

  Zheng, N ^a   Wang, C X ^a   Zhang, X ^a   Du, L T ^a   Zhang, J ^a   Kan, S F ^a   Zhu, C B ^b   Dong, Z G ^a   Wang, L L ^a   Wang, S ^a   Li, W ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Carbohydrate antigen 125; Cervical lesion; Human leukocyte antigen G; Squamous cell carcinoma antigen

Indexed keywords

CA 125 ANTIGEN; HLA G ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UPREGULATION; UTERINE CERVIX CANCER;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; UP-REGULATION; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79551673982     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01607.x     Document Type: Article

References (20)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005: 55: 74-108.
2. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?Cancer Res 2005: 65: 10139-44.
3. Seliger B, Abken H, Ferrone S. HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends Immunol 2003: 24: 82-7.
4. Ibrahim EC, Aractingi S, Allory Y et al. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype. Int J Cancer 2004: 108: 243-50.
5. Sheu JJ, Shih IeM. Clinical and biological significance of HLA-G expression in ovarian cancer. Semin Cancer Biol 2007: 17: 436-43.
6. Yoon BS, Kim YT, Kim JW, Kim SH, Kim JH, Kim SW. Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma. Int J Gynaecol Obstet 2007: 98: 48-53.
7. Lin A, Chen HX, Zhu CC et al. Aberrant human leukocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma. J Cell Mol Med 2010: 14: 2162-71.
8. Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H. Quantification and identification of soluble HLA-G isoforms. Tissue Antigens 2007: 69 (Suppl 1): 143-9.
9. Pistoia V, Morandi F, Wang X, Ferrone S. Soluble HLA-G: are they clinically relevant?Semin Cancer Biol 2007: 17: 469-79.
10. Ugurel S, Rebmann V, Ferrone S et al. Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer 2001: 92: 369-76.
11. Wiendl H, Mitsdoerffer M, Hofmeister V et al. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 2002: 168: 4772-80.
12. Rebmann V, Regel J, Stolke D, Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 2003: 13: 371-7.
13. Leleu X, Le Friec G, Facon T et al. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance. Clin Cancer Res 2005: 11: 7297-303.
14. Gros F, Sebti Y, de Guibert S et al. Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia 2006: 8: 223-30.
15. Morandi F, Levreri I, Bocca P et al. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release. Cancer Res 2007: 67: 6433-41.
16. Garrido F, Cabrera T, Accolla RS et al. HLA and cancer: 12th International Histocompatibility Workshop study. In: Charron D, ed. Genetic Diversity of HLA. Functional and Medical Implication. Proceedings of the Twelfth International Histocompatibility Workshop and Conference, Vol. II. France EDK, Sevres, 1997, 445-52.
17. Wiendl H, Mitsdoerffer M, Schneider D et al. Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies. Brain 2003: 126: 1026-35.
18. Singer G, Rebmann V, Chen YC et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003: 9: 4460-4.
19. Edelstein ZR, Madeleine MM, Hughes JP et al. Age of diagnosis of squamous cell cervical carcinoma and early sexual experience. Cancer Epidemiol Biomarkers Prev 2009: 18: 1070-6.
20. Gage JC, Hanson VW, Abbey K et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006: 108: 264-7.